Every Form 4 that Alkami Technology, Inc. (ALKT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ALKT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALKT filings page.
ALKAMI TECHNOLOGY, INC. (ALKT) reported that Chief Executive Officer and director Alex Shootman had 16,188 shares of common stock withheld on September 8, 2026 to satisfy tax withholding obligations related to vesting and settlement of restricted stock units. After this tax-withholding disposition, he holds 1,169,409 shares of Alkami common stock directly.
ALKAMI TECHNOLOGY, INC. (ALKT) reported that Chief Accounting Officer Prerna Sachdeva had 1,421 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations related to vesting of restricted stock units. After this withholding, she directly held 85,001 shares of common stock.
No Rule 10b5-1 trading plan is reported for this transaction, which is characterized as stock withheld for taxes rather than an open-market sale.
ALKAMI TECHNOLOGY, INC. (ALKT) reported that Chief Legal Officer Douglas A. Linebarger had 7,381 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. After this tax-withholding disposition, he held 337,265 shares of common stock directly, and no Rule 10b5-1 trading plan is reported in connection with this event.
ALKAMI TECHNOLOGY, INC. (ALKT) reported that Chief Financial Officer Cassandra Hudson had 8,293 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. The shares were valued at $19.44 per share for this withholding, and Hudson now holds 324,458 shares of Alkami common stock directly. No Rule 10b5-1 trading plan is reported for this transaction.
ALKAMI TECHNOLOGY, INC. (ALKT) reported that Chief Executive Officer and director Alex Shootman had 5,205 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations tied to vesting restricted stock units, at a value of $19.44 per share. After this tax-withholding disposition, he directly holds 1,185,597 shares of Alkami common stock. No Rule 10b5-1 trading plan is reported for this transaction.
HUDSON CASSANDRA reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. reported that Chief Financial Officer Cassandra Hudson received a grant of 52,116 restricted stock units (RSUs) of common stock on August 7, 2026. According to the award terms, these RSUs vest in 16 quarterly installments starting from a vesting commencement date of June 1, 2026. Each RSU represents a contingent right to receive one share of common stock, contributing to a reported total direct holding of 332,751 shares of common stock after this grant.
FOX JEFFREY H reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Jeffrey H. Fox received a grant of 457 shares of Common Stock as compensation, recorded at a price of $0.00 per share. After this award, he directly holds 20,780 shares. According to the footnote, he elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan.
Linville Judson C reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Judson C. Linville reported receiving a grant of 457 shares of common stock as compensation, at a stated price of $0.00 per share. After this award, he directly holds 20,780 shares. According to the disclosure, he elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan, making this a structured, plan-based equity grant rather than an open-market transaction.
Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Maria Ines Alvarez reported receiving an award of 685 shares of Common Stock, recorded at a price of $0.00 per share. This is a compensation-related grant, not an open-market purchase. Following the award, she holds 70,594 shares directly. The filing notes she elected to defer receipt of these shares under the company’s 2021 Incentive Award Plan.
Mitchell Steven R reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Steven R. Mitchell reported an equity award and updated share holdings. He received a grant of 533 shares of common stock with no cash paid per share, increasing his direct holdings to 98,026 shares.
The filing also reports 2,521,611 shares of common stock held indirectly through ARG Private Equity II, LLC, an entity with which Mitchell is associated. He may be deemed to have beneficial ownership of those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
SMITH BRIAN R reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director and 10% owner Brian R. Smith received a grant of 1,180 shares of Common Stock at $0.00 per share as a compensation award. He elected to defer receipt of these shares under the 2021 Incentive Award Plan. Following the grant, he holds 565,722 shares directly and 14,218,240 shares indirectly through S3 Ventures Fund III, L.P., with associated entities and Smith disclaiming beneficial ownership beyond their pecuniary interests.
ALKAMI TECHNOLOGY, INC. Chief Executive Officer Alex Shootman reported a tax-related share disposition tied to equity compensation. The Form 4 shows that 16,188 shares of Common Stock were withheld by the company at $15.85 per share to cover his tax obligations when restricted stock units vested and settled. This was not an open-market sale, but an automatic withholding mechanism. After this event, Shootman directly holds 1,190,802 shares of Common Stock.
ALKAMI TECHNOLOGY, INC. Chief Legal Officer Douglas A. Linebarger reported a routine tax-related share disposition. On June 1, 2026, 5,819 shares of common stock were withheld by the company at $18.95 per share to cover his tax obligations from vesting restricted stock units. After this withholding, he directly holds 344,646 shares of Alkami common stock. This was not an open-market sale, but an automatic mechanism to satisfy taxes due on equity compensation.
ALKAMI TECHNOLOGY, INC. Chief Executive Officer Alex Shootman reported a routine tax-related share disposition. The company withheld 5,205 shares of common stock at $18.95 per share to cover his tax withholding obligations arising from the vesting and settlement of restricted stock units. After this withholding, he directly holds 1,206,990 shares of common stock, which includes 1,221 shares acquired through the company’s employee stock purchase plan.
ALKAMI TECHNOLOGY, INC. Chief Financial Officer Cassandra Hudson reported a tax-related share disposition. On the vesting and settlement of restricted stock units, 6,122 shares of common stock were withheld by the company to satisfy her tax withholding obligations at a price of $18.95 per share. This was not an open-market sale. After this withholding, she directly owned 280,635 shares of Alkami common stock.
ALKAMI TECHNOLOGY, INC. Chief Accounting Officer Prerna Sachdeva had 1,370 shares of common stock withheld at $18.95 per share to cover tax obligations tied to vesting restricted stock units. After this tax-withholding disposition, she directly holds 86,422 shares, so this is a routine compensation-related event rather than an open-market sale.
ALKAMI TECHNOLOGY, INC. director Judson C. Linville received an initial equity grant linked to company stock. He was awarded 20,323 shares as a restricted stock unit (RSU) award at no cash cost, bringing his reported direct common stock holdings to 20,323 shares after the transaction.
The footnote explains that this Initial RSU Award will vest in three equal installments, with one-third vesting on each anniversary of the grant date and becoming fully vested on the third anniversary. Linville elected to defer receipt of these shares under the company’s 2021 Incentive Plan, making this a compensation-related, non-cash acquisition rather than an open-market purchase.
FOX JEFFREY H reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Jeffrey H. Fox received an initial restricted stock unit (RSU) award covering 20,323 shares of common stock on the reported date. The RSUs vest in equal one-third installments on each anniversary of the grant and will be fully vested after three years. Fox elected to defer receipt of these shares under the company’s 2021 Incentive Plan, and his direct holdings reported after this grant total 20,323 shares.
Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.
Alkami Technology director Maria Ines Alvarez received a grant of 11,357 restricted stock units (RSUs) of common stock. Each RSU represents a right to receive one share. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date. After this award, she holds 69,909 shares directly and has elected to defer receipt of the shares under the company’s 2021 Incentive Plan.
ALKAMI TECHNOLOGY, INC. director Charles Kane reported an equity award on Form 4. He received a grant of 11,357 restricted stock units (RSUs) of common stock at no cash purchase price, classified as a grant or award acquisition. These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting following the grant date. Each RSU represents a contingent right to receive one share of common stock, and Kane has elected to defer receipt of these shares under the company’s 2021 Incentive Plan. Following this award, his directly held stake reported in the filing is 54,646 shares/RSUs.
Morgan Susanna reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Susanna Morgan reported an equity compensation grant in the form of restricted stock units. She received 11,357 RSUs, each representing a contingent right to one share of common stock, bringing her direct holdings to 23,126 shares reported after the award.
The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date. Morgan elected to defer receipt of the underlying shares under the company’s 2021 Incentive Plan, indicating this is a structured, compensation-related award rather than a market purchase.
Mitchell Steven R reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Steven R. Mitchell received a grant of 11,357 restricted stock units (RSUs) of common stock. These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date, and he elected to defer receipt of the shares under the 2021 Incentive Plan.
After this award, Mitchell directly holds 97,493 shares of common stock. Separately, 2,521,611 shares are held indirectly through ARG Private Equity II, LLC, where he serves as an adviser and may be deemed a beneficial owner, though he disclaims beneficial ownership except to the extent of his pecuniary interest.
ALKAMI TECHNOLOGY, INC. director Raphael Osnoss received an equity award of 11,357 restricted stock units (RSUs). The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date. Each RSU converts into one share of common stock upon settlement, and the reporting person has elected to defer receipt of these shares under the company’s 2021 Incentive Plan. Following this grant, Osnoss directly holds 53,313 shares of common stock.
Payne Joseph P. reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Joseph P. Payne received a grant of 11,357 shares of Common Stock in the form of restricted stock units. The award was granted at no cash cost to him. These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the Annual Meeting following the grant date. Each RSU represents a contingent right to receive one share of common stock. Following this grant, Payne directly holds 37,985 shares of the company’s stock.
Yastine Barbara A. reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Barbara A. Yastine received an equity grant of 11,357 shares of common stock in the form of restricted stock units (RSUs). These RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting following the grant date. After this award, she holds 92,113 common shares directly, giving her increased equity exposure aligned with shareholders over the coming year.
Alkami Technology director and 10% owner Brian R. Smith received a grant of 11,357 restricted stock units (RSUs) of common stock. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next annual meeting, and each RSU converts into one share. Smith elected to defer receipt of these shares under the company’s 2021 Incentive Plan. Following this award, he holds 564,542 shares directly. Entities affiliated with S3 Ventures Fund III report indirect ownership of 14,218,240 shares, with certain parties disclaiming beneficial ownership beyond their pecuniary interest.
Alkami Technology’s major shareholder group made sizable open-market purchases of Common Stock. Investment entity GA AL Holding II, L.P. acquired 750,000 shares on May 12, 550,000 shares on May 13, and 675,000 shares on May 14, 2026, at weighted average prices around $16.87, $16.63, and $16.49 per share.
After these transactions, entities affiliated with General Atlantic reported indirect beneficial ownership of 19,420,994 Alkami shares, held across several related funds and vehicles. All trades were open-market buys, indicating increased exposure through these affiliated investment partnerships.
ALKAMI TECHNOLOGY, INC. reported significant insider buying by entities affiliated with General Atlantic. Through GA AL Holding II, L.P., these funds acquired a total of 1,975,000 shares of common stock in open-market purchases on May 12–14, 2026, at weighted average prices of $16.87, $16.63, and $16.49 per share. After these transactions, General Atlantic–associated entities indirectly held 19,420,994 Alkami shares across several investment funds and related vehicles.
Investment funds affiliated with General Atlantic increased their indirect stake in Alkami Technology through open market purchases. GA AL Holding II, L.P. acquired 521,771 shares of Common Stock on May 4, 2026 at a weighted average price of $16.92, 700,000 shares on May 5, 2026 at $16.84, and 844,772 shares on May 6, 2026 at $16.63, for a total of 2,066,543 shares. After these trades, entities in the General Atlantic structure indirectly held 17,445,994 Alkami shares through various affiliated limited partnerships and investment funds, with economic interests ultimately allocated across multiple General Atlantic vehicles.
ALKAMI TECHNOLOGY, INC. received significant additional investment from General Atlantic–affiliated entities through a series of open‑market purchases of Common Stock. GA AL Holding II, L.P. acquired 521,771 shares on May 4, 700,000 shares on May 5, and 844,772 shares on May 6, 2026, totaling 2,066,543 shares. Following these transactions, affiliated investment vehicles collectively reported 17,445,994 shares of Alkami common stock held indirectly.
Alvarez Maria Ines reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. director Maria Ines Alvarez received an award of 674 shares of Common Stock on April 5, 2026 at a stated price of $0.00 per share. This was a grant under the company’s 2021 Incentive Award Plan, and she elected to defer receipt of these shares under that plan. Following this award, she directly holds 58,552 shares of Common Stock.
SMITH BRIAN R reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY director and 10% owner Brian R. Smith received a grant of 1,160 shares of Common Stock as a compensation award. The shares were granted at no cost under the 2021 Incentive Award Plan, and he elected to defer receipt of these shares.
After this award, Smith holds 553,185 shares directly. In addition, 14,218,240 shares are held indirectly through S3 Ventures Fund III, L.P., where related S3 entities and Smith may be deemed to share beneficial ownership, although each disclaims beneficial ownership beyond their pecuniary interest.
Mitchell Steven R reported acquisition or exercise transactions in this Form 4 filing.
Alkami Technology, Inc. director Mitchell Steven R received a grant of 524 shares of common stock at no cost as a stock award. These shares were elected to be deferred under the company’s 2021 Incentive Award Plan, so he will receive them at a later time.
After this award, his directly held common stock totals 86,136 shares. Separately, 2,521,611 shares are held by ARG Private Equity II, LLC, where he serves as an adviser and may be deemed to have beneficial ownership only to the extent of his pecuniary interest.
ALKAMI TECHNOLOGY, INC. reported an open-market insider purchase by investment entities affiliated with General Atlantic. On March 12, 2026, GA AL Holding II, L.P. acquired 500,000 shares of common stock at a weighted average price of $18.33 per share. Following this transaction, investment funds and related entities associated with General Atlantic collectively held 15,379,451 shares indirectly. The footnotes explain that these shares are spread across multiple General Atlantic funds and coinvestment vehicles, reflecting a large, coordinated institutional position rather than an individual insider trade.
Alkami Technology reported an insider purchase by investment funds affiliated with General Atlantic. GA AL Holding II, L.P. acquired 500,000 shares of Alkami common stock in open-market transactions at a weighted average price of $18.33 per share, with trade prices ranging from $18.30 to $18.36. Following this transaction, General Atlantic–affiliated vehicles collectively report beneficial ownership of 15,379,451 shares through multiple related funds and entities.
Alkami Technology director Joseph P. Payne bought 5,500 shares of common stock in an open-market transaction. He paid $18.225 per share on this purchase. After the transaction, Payne directly owns 26,628 Alkami Technology common shares, according to the Form 4 filing.
ALKAMI TECHNOLOGY, INC. received significant insider interest as investment entities affiliated with General Atlantic reported open-market purchases of common stock. GA AL Holding II, L.P., a Bermuda limited partnership, acquired 842,266 shares on March 9, 2026 at a weighted average price of $17.35, 1,103,749 shares on March 10, 2026 at $17.56, and 900,000 shares on March 11, 2026 at $18.41.
Across the three days, the reporting group bought a total of 2,846,015 Alkami common shares in open-market transactions, all held indirectly. Following these purchases, entities associated with the reporting persons collectively held 14,879,451 shares of Alkami common stock through several General Atlantic funds and related vehicles, according to the ownership breakdown in the footnotes.
ALKAMI TECHNOLOGY, INC. reported a Form 4 showing that investment entities affiliated with General Atlantic increased their indirect stake through open-market purchases of common stock. GA AL Holding II, L.P. acquired a total of 2,846,015 shares over three days at weighted average prices between $17.35 and $18.41 per share. Following these transactions, the reporting group indirectly holds 14,879,451 shares of Alkami common stock. The filing explains that these shares are held across multiple related General Atlantic funds and coinvestment vehicles that share beneficial ownership.
Alkami Technology, Inc. Chief Executive Officer Alex Shootman reported an open-market sale of 10,876 shares of common stock at $16.59 per share. According to the footnote, this sale was executed solely to cover tax withholding obligations arising from the vesting and settlement of restricted stock units under a "sell to cover" arrangement, and is described as non-discretionary. After the transaction, Shootman directly holds 1,210,974 shares of Alkami common stock, so the sale represents only a small portion of his overall equity position.
Shootman Alex reported acquisition or exercise transactions in this Form 4 filing.
ALKAMI TECHNOLOGY, INC. Chief Executive Officer Alex Shootman reported two equity awards of common stock in the form of restricted stock units (RSUs). One grant covers 211,609 RSUs that vest in 16 quarterly installments starting on March 1, 2026, with each RSU convertable into one share of common stock upon vesting. A second grant covers 211,608 RSUs that vest in four equal annual installments beginning on March 1, 2027, and the underlying shares are subject to transfer restrictions for one year after each vesting date. Following these awards, his reported direct holdings in common stock increased, reflecting additional equity-based compensation rather than open-market purchases.
Alkami Technology chief legal officer Douglas A. Linebarger reported equity awards and a small tax-related share sale. On March 4, 2026, he acquired 66,506 and 66,505 shares of common stock at $0.00 per share as restricted stock unit (RSU) awards.
One RSU grant vests in 16 quarterly installments starting March 1, 2026, and the other vests in four annual installments beginning March 1, 2027, with a one-year transfer restriction after each vest. On March 2, 2026, he sold 5,518 shares at $16.90 per share to cover tax withholding obligations from RSU vesting under a sell-to-cover arrangement, described as non-discretionary.
Alkami Technology Chief Accounting Officer Prerna Sachdeva reported both a stock award and a related share sale. On March 1, 2026, she received 24,184 restricted stock units that vest in 16 quarterly installments, with each RSU convertible into one share of common stock.
On March 2, 2026, she sold 1,352 common shares at $16.90 per share. According to the disclosure, this sale was made solely to cover tax withholding obligations through a “sell to cover” transaction and is described as not being a discretionary trade.
ALKAMI TECHNOLOGY, INC. Chief Financial Officer Cassandra Hudson reported an open-market sale of 6,869 shares of common stock at $16.90 per share on March 2, 2026. According to the filing, this sale was executed solely to cover tax withholding obligations arising from the vesting and settlement of restricted stock units through a “sell to cover” transaction, and is described as not being a discretionary trade by the executive. Following this tax-related sale, Hudson directly holds 286,757 shares of Alkami common stock.
Alkami Technology, Inc. director and 10% owner Brian R. Smith reported an acquisition of common stock. On January 5, 2026, he acquired 877 shares of Alkami common stock at $0.00 per share by electing to defer receipt of these shares under the company’s 2021 Incentive Award Plan, bringing his directly held stake to 552,025 shares.
The filing also reports 14,218,240 shares of Alkami common stock held indirectly by S3 Ventures Fund III, L.P. S3 Ventures GPLP III, L.P., S3 Ventures III, L.L.C., and Mr. Smith may be deemed to beneficially own these shares through their roles with the fund, but each disclaims beneficial ownership except to the extent of their pecuniary interest.
Alkami Technology, Inc. director Maria Ines Alvarez reported acquiring 255 shares of common stock on January 5, 2026 at a price of $0 per share. This increased her beneficial ownership to 57,878 common shares held directly. The filing indicates this was a non-derivative equity transaction coded as an acquisition, meaning no option or warrant was involved. The transaction was reported on a Form 4 filed for a single reporting person, reflecting a relatively small change in her overall share holdings.
Alkami Technology director Steven R. Mitchell reported receiving 396 shares of common stock on January 5, 2026, at a price of $0 per share. These shares were elected to be deferred under the company’s 2021 Incentive Award Plan and increased his directly held position to 85,612 common shares. In addition, 2,521,611 common shares are reported as indirectly owned through ARG Private Equity II, LLC, where he serves as an adviser. He may be deemed to have beneficial ownership of those indirect shares but expressly disclaims beneficial ownership except to the extent of his pecuniary interest.
Alkami Technology, Inc.'s Chief Accounting Officer reported a small stock sale related to equity compensation. On 12/02/2025, the officer sold 1,101 shares of common stock at $20.34 per share. According to the disclosure, this sale was made solely to cover tax withholding obligations tied to the vesting and settlement of restricted stock units, and is described as not being a discretionary trade. After this transaction, the officer beneficially owned 64,960 shares of Alkami Technology common stock.
Alkami Technology (ALKT) disclosed that its Chief Executive Officer and director, Alex Shootman, acquired 45,000 shares of common stock on November 7, 2025 at $19.45 per share.
After this transaction, Shootman beneficially owned 841,563 shares, held directly. The acquisition was from the issuer in a transaction approved by the company’s board of directors.
Brian R. Smith, a director and reported 10% owner of Alkami Technology, Inc. (ALKT), reported transactions dated 10/05/2025. He elected to defer receipt of 786 common shares under the company's 2021 Incentive Award Plan at a stated price of $0, which increased his directly held shares to 551,148. The filing also discloses 14,218,240 shares held indirectly by S3 Ventures Fund III, L.P., for which Mr. Smith may be deemed to have beneficial ownership through the fund and related entities; those entities disclaim beneficial ownership except to the extent of pecuniary interest. Signatures show the filing was executed on 10/07/2025.
Insider transaction summary: A Form 4 shows director Steven R. Mitchell reported an acquisition of 347 shares of Alkami Technology, Inc. (ALKT) on 10/05/2025, with an elected deferral under the 2021 Incentive Award Plan, priced at $0 to reflect the deferred issuance terms. The filing also discloses an indirect beneficial interest in 2,521,611 shares held by ARG Private Equity II, LLC (APE II), for which Mr. Mitchell serves as an adviser and disclaims beneficial ownership except for his pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/07/2025.